• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对考虑体内质子射程验证的新治疗计划方法。

Toward a new treatment planning approach accounting for in vivo proton range verification.

机构信息

Department of Medical Physics, Ludwig-Maximilians-Universität München, Munich, Germany. Author to whom any correspondence should be addressed.

出版信息

Phys Med Biol. 2018 Oct 30;63(21):215025. doi: 10.1088/1361-6560/aae749.

DOI:10.1088/1361-6560/aae749
PMID:30375361
Abstract

Protons with modern pencil-beam scanning delivery are widely used in state-of-the-art radiotherapy. To reduce the unwanted effect of proton range uncertainties, prompt gamma (PG) monitoring is investigated and considered one of the most promising methods for real-time, in vivo range verification. Despite good correlation between the penetration depth of the PG signal and proton range in most cases, mismatch can occur especially because of tissue heterogeneities. Moreover, detectability and reproducibility of the prompt gamma signal critically depends on counting statistics. Nowadays, conventional treatment planning systems do not account for the degree of correlation between dose and PG signal nor the expected PG signal counting statistics, which considerably influences the possibility of a reliable verification of the intended beam range. Hence, in this project, we investigate a new treatment planning approach, in which the spot-by-spot conformities between PG and dose profiles (PG-dose correlation) as well as PG signal detectability and precision are taken into account based on a TPS optimizer. To investigate the feasibility of this idea, a research computational platform, combining Monte Carlo (MC, Geant4) pre-calculated pencil beams with the analytical Matlab-based TPS engine CERR, is used for treatment planning. Geant4 is employed for realistic simulation of the dose delivery and PG generation of all spots in the heterogeneous patient anatomy given by CT images. First of all, a treatment plan is created using a charged particle extension of CERR. Secondly, the PG fall-off positions of all individual pencil beams are evaluated and compared to the 80% distal dose fall-off positions. Thirdly, the PG-dose correlations of all spots are quantified. A new plan, in which a few spots with the best PG-dose correlation are boosted to ensure PG detectability with good precision, is then made. Finally, the optimized plan is fully recalculated on the same patient CT using Geant4, and the result is evaluated considering both plan quality and beam range monitorability. The evaluation shows that the re-optimized treatment plan is comparable to the initial plan in terms of dose distribution, dose averaged LET distribution and robustness, while fulfilling the set statistical conditions for reliable PG monitoring of the few automatically or manually selected spots. The method could thus complement, and for the selected pencil beams even overcome limitations of, alternative suggested approach such as pencil beam aggregation to provide sufficient counting statistics for precise PG range retrieval with good correlation to the treatment dose.

摘要

质子的现代笔形扫描输送被广泛应用于最先进的放射治疗中。为了减少质子射程不确定性的不良影响,人们研究了瞬发伽马(PG)监测,并认为这是实时体内射程验证最有前途的方法之一。尽管在大多数情况下,PG 信号的穿透深度与质子射程之间存在很好的相关性,但特别是由于组织不均匀性,可能会出现不匹配的情况。此外,瞬发伽马信号的可探测性和再现性严重依赖于计数统计。如今,传统的治疗计划系统不考虑剂量与 PG 信号之间的相关性程度,也不考虑预期的 PG 信号计数统计,这极大地影响了可靠验证预期射束射程的可能性。因此,在这个项目中,我们研究了一种新的治疗计划方法,该方法基于 TPS 优化器考虑了 PG 与剂量分布之间的逐点一致性(PG-剂量相关性)以及 PG 信号的可探测性和精度。为了研究这个想法的可行性,我们使用一个结合了蒙特卡罗(MC、Geant4)预计算笔形束与基于 Matlab 的分析性 TPS 引擎 CERR 的研究计算平台进行治疗计划。Geant4 用于对来自 CT 图像的异质患者解剖结构中的所有点的剂量输送和 PG 生成进行现实模拟。首先,使用 CERR 的带电粒子扩展创建治疗计划。其次,评估并比较所有单个笔形束的 PG 衰减位置与 80%远端剂量衰减位置。第三,量化所有点的 PG-剂量相关性。然后制作一个新的计划,其中几个具有最佳 PG-剂量相关性的点被提升,以确保具有良好精度的 PG 可探测性。最后,使用 Geant4 在同一患者 CT 上重新计算优化后的计划,并根据计划质量和束流范围可监测性进行评估。评估结果表明,重新优化的治疗计划在剂量分布、剂量平均 LET 分布和稳健性方面与初始计划相当,同时满足了为少数自动或手动选择的点进行可靠 PG 监测设定的统计条件。因此,该方法可以补充,甚至对于选定的笔形束,可以克服例如笔形束聚集等替代建议方法的限制,为精确的 PG 射程检索提供足够的计数统计,并与治疗剂量具有良好的相关性。

相似文献

1
Toward a new treatment planning approach accounting for in vivo proton range verification.针对考虑体内质子射程验证的新治疗计划方法。
Phys Med Biol. 2018 Oct 30;63(21):215025. doi: 10.1088/1361-6560/aae749.
2
A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.一种新的治疗计划方法,考虑了瞬发伽马射线范围验证和分次间解剖变化。
Phys Med Biol. 2020 Apr 29;65(9):095005. doi: 10.1088/1361-6560/ab7d15.
3
Accounting for prompt gamma emission and detection for range verification in proton therapy treatment planning.在质子治疗计划中进行位置验证时考虑到了瞬发伽马射线的发射和探测。
Phys Med Biol. 2021 Feb 16;66(5):055005. doi: 10.1088/1361-6560/abc939.
4
Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.关于前列腺癌患者分次间变化导致的质子射程改变对即时伽马成像敏感性的蒙特卡罗研究。
Phys Med Biol. 2015 Dec 21;60(24):9329-47. doi: 10.1088/0031-9155/60/24/9329. Epub 2015 Nov 18.
5
Monte Carlo proton dose calculations using a radiotherapy specific dual-energy CT scanner for tissue segmentation and range assessment.使用放疗专用双能 CT 扫描仪进行组织分割和射程评估的蒙特卡罗质子剂量计算。
Phys Med Biol. 2018 May 29;63(11):115008. doi: 10.1088/1361-6560/aabb60.
6
An algorithm to assess the need for clinical Monte Carlo dose calculation for small proton therapy fields based on quantification of tissue heterogeneity.一种基于组织不均匀性量化的小型质子治疗场临床蒙特卡罗剂量计算需求评估算法。
Med Phys. 2013 Aug;40(8):081704. doi: 10.1118/1.4812682.
7
Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification.使用康普顿相机对临床质子束传输过程中发射的瞬发伽马射线进行成像:射程验证的可行性研究。
Phys Med Biol. 2015 Sep 21;60(18):7085-99. doi: 10.1088/0031-9155/60/18/7085. Epub 2015 Aug 28.
8
Monte Carlo evaluation of tissue inhomogeneity effects in the treatment of the head and neck.头部和颈部治疗中组织不均匀性效应的蒙特卡罗评估
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1339-49. doi: 10.1016/s0360-3016(01)01614-5.
9
Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.蒙特卡罗患者研究比较了质子治疗中用于射程验证的瞬发伽马和 PET 成像。
Phys Med Biol. 2011 Feb 21;56(4):1063-82. doi: 10.1088/0031-9155/56/4/012. Epub 2011 Jan 25.
10
Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.强度调制质子治疗脑和单侧头颈部肿瘤中的综合射束方向和扫描野优化。
Med Phys. 2018 Apr;45(4):1338-1350. doi: 10.1002/mp.12788. Epub 2018 Mar 1.

引用本文的文献

1
Comparison of reconstructed prompt gamma emissions using maximum likelihood estimation and origin ensemble algorithms for a Compton camera system tailored to proton range monitoring.针对质子射程监测定制的康普顿相机系统,使用最大似然估计和起源集总算法对重建的提示伽马发射进行比较。
Z Med Phys. 2023 May;33(2):124-134. doi: 10.1016/j.zemedi.2022.04.005. Epub 2022 Jun 21.
2
On-line range verification for proton beam therapy using spherical ionoacoustic waves with resonant frequency.利用具有谐振频率的球形离子声波进行质子束治疗的在线剂量验证。
Sci Rep. 2020 Nov 23;10(1):20385. doi: 10.1038/s41598-020-77422-2.
3
Roadmap: proton therapy physics and biology.
质子治疗物理与生物学路线图
Phys Med Biol. 2021 Feb 26;66(5). doi: 10.1088/1361-6560/abcd16.
4
Latest developments in in-vivo imaging for proton therapy.用于质子治疗的活体成像的最新进展。
Br J Radiol. 2020 Mar;93(1107):20190787. doi: 10.1259/bjr.20190787. Epub 2019 Dec 12.